Skip to content
drillr.ai
Sign up

GLMD

Galmed Pharmaceuticals Ltd.

NASDAQ · Healthcare · Biotechnology · IL

$3.88
−1.02%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue—————
Cost of Revenue—————
Gross Profit—————
Operating Expenses
R&D Expense6.3M4.9M3.0M3.6M13.0M
SG&A Expense3.6M3.6M3.3M3.9M4.7M
General & Admin Expense2.6M3.6M3.3M3.9M4.7M
Selling & Marketing Expense—————
Other Expenses—————
Total Operating Expenses10.0M8.5M6.3M7.5M17.7M
Cost and Expenses10.0M8.5M6.3M7.5M17.7M
Operating Income (EBIT)(10.0M)(8.5M)(6.3M)(7.5M)(17.7M)
Non-Operating
Interest Income902.0K914.0K503.0K375.0K297.0K
Interest Expense102.0K—15.0K11.0K215.0K
Net Interest Income800.0K914.0K488.0K364.0K82.0K
Other Non-Op Income/Expense(1.4M)(1.8M)(1.2M)580.0K(215.0K)
Non-Operating Income (excl Interest)1.6M1.8M1.2M(591.0K)—
EBT (Pre-Tax Income)(11.3M)(10.3M)(7.5M)(6.9M)(17.9M)
Income Tax Expense—————
Bottom Line
Net Income(11.3M)(10.3M)(7.5M)(6.9M)(17.9M)
Earnings from Cont. Ops(11.3M)(10.3M)(7.5M)(6.9M)(17.9M)
Earnings from Discont. Ops—————
Bottom Line Net Income(11.3M)(10.3M)(7.5M)(6.9M)(17.9M)
Per Share
Basic EPS($13.82)($19.12)($64.64)($240.40)($88.64)
Diluted EPS($13.82)($19.12)($64.64)($239.60)($88.64)
Revenue Per Share$0.00$0.00$0.00$0.00$0.00
Shares
Basic Shares Outstanding95216853891511635328750209523
Diluted Shares Outstanding95216853891511635328849209523
Profitability Metrics
EBITDA(11.5M)(10.3M)(7.4M)(6.9M)(17.6M)
D&A——83.0K31.0K35.0K
EBIT(11.5M)(10.3M)(7.5M)(6.9M)(17.7M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026